What company makes Mounjaro, and why does it matter?

Which company makes Mounjaro, and what is tirzepatide exactly?

Eli Lilly and Company is the pharmaceutical company behind Mounjaro. Lilly researchers spent years developing tirzepatide (the molecule at the heart of Mounjaro) as a dual receptor agonist that works on both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) pathways at the same time. No other weight-loss medicine licensed in the UK does this; semaglutide, made by Novo Nordisk, targets the GLP-1 receptor alone. If you want to read more about how the two compare, the tirzepatide overview on this site sets out the mechanism in plain language.

Lilly first gained approval for tirzepatide in the United States in 2022. UK approval followed, and the MHRA-authorised product is sold here as Mounjaro — not as Zepbound, which is the US brand name and does not exist as a UK product. For weight management, the NHS medicines page for tirzepatide gives a clear patient-level summary of how it works and what to expect.

Lilly supplies Mounjaro to the UK through authorised wholesalers and licensed pharmacies. Medicines dispensed outside that chain (from unverified online sellers or social media contacts) carry serious safety risks, a point the MHRA has made repeatedly in public warnings about counterfeit weight-loss pens.

Does Eli Lilly sell Mounjaro directly to patients?

No. Eli Lilly manufactures Mounjaro and holds the UK marketing authorisation, but the company does not prescribe or dispense to patients. That role belongs to licensed pharmacies and prescribers. To use Mounjaro legally in the UK you need a valid prescription, issued after a clinical assessment by a qualified prescriber, a GP, a specialist, or a GPhC-registered Independent Prescriber working through a regulated online pharmacy.

It is worth understanding this because some patients search for ways to obtain Mounjaro directly from the manufacturer or at a perceived "manufacturer price". Eli Lilly sets the list price at which it sells to wholesalers; pharmacies and clinics then set their own charges. Since Lilly raised Mounjaro's UK list price from around £122 to around £330 per four-week pen in September 2025 (as widely reported at the time), private charges across the market have reflected that shift. For context on how those costs break down, the Mounjaro treatment page explains what a legitimate private prescription typically covers.

If you are wondering which type of provider to use, our guide on finding a reputable Mounjaro provider walks through the key questions to ask any pharmacy or clinic before you hand over any personal or financial details.

What does Eli Lilly's involvement mean for supply and quality?

Lilly's name on the box matters for one practical reason: supply chain legitimacy. Mounjaro produced by Eli Lilly and distributed through the licensed UK wholesale network has been manufactured to MHRA standards, with full batch testing and cold-chain controls. Counterfeit pens seized in the UK have included dangerous substances (the first illicit UK manufacturing site producing fake tirzepatide pens was raided in 2025) so verifying that your medicine came through that licensed chain is not a formality.

When a pharmacy is GPhC-registered and sources through authorised UK wholesalers, it can trace every pen back to Lilly. You can check any online pharmacy on the GPhC pharmacy register in about thirty seconds; it is the single most reliable way to confirm legitimacy before you share any health information. The page on getting Mounjaro online safely covers the red flags in detail.

A quick note on timing: if your payday or a bank holiday affects when you place an order, Lilly's supply chain operates continuously, so stock availability at a legitimate pharmacy is not disrupted by those dates, though delivery logistics depend on the working day.

For the broader picture on what's available for weight loss in the UK, the weight-loss treatments overview is a good starting point, and our frequently asked questions cover the practical details patients most often raise before their first consultation.

Is tirzepatide made by any other company in the UK?

No. Eli Lilly holds the exclusive UK marketing authorisation for tirzepatide under the Mounjaro brand. There is no licensed generic tirzepatide in the UK at the time of writing, and no other manufacturer is authorised to produce or sell it here. Compounded or "unlicensed" versions of tirzepatide are not MHRA-approved and carry significant safety uncertainty.

The tirzepatide drug company page goes into more detail on how Lilly's authorisation works and why the absence of a licensed generic matters for patients. If your question is more specifically about who owns the intellectual property and commercial rights, the Mounjaro ownership page covers that ground. And if you are ready to explore whether Mounjaro could be right for you, speaking to a prescriber is always the proper next step, you can start your free consultation with the nume clinical team at any point.